chrisvoncsefalvay/vaers-outcomes huggingface dataset:
got covid infection after the first dose.14 days from the second dose; got covid infection after the first dose.14 days from the second dose; This is a spontaneous report from a Pfizer sponsored program from a contactable consumer. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose 0n an unspecified date for COVID-19 immunisation. Medical history and concomitant medication were not reported. Patient had 21 days recommendation inquiry for covid. Patient got covid infection after the first dose. 14 days from the second dose (as reported). Patient was inquiring timeline for second dose. Covid test was positive. The outcome of events was unknown.  The information on the lot/batch number has been requested.
eveytime I did, I got sick for 2 months straight; Initial information received on 18-Oct-2023 regarding an unsolicited valid social media non-serious case received from a patient.  This case involves an unknown age and gender patient who had got sick for 2 months straight after receiving Influenza Vaccine.  The patient's past medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, formulation, batch number, expiry date unknown) via unknown route in unknown administration site for Prophylactic vaccination (immunization).  On an unknown date the patient got sick for 2 months straight (illness) (unknown latency) following the administration of influenza vaccine.  Reportedly, patient don't do flu shots for 20 years. Because every time patient did, patient got sick for 2 months straight. When patient haven't it last 3 weeks.  It is unknown if the patient experienced any additional symptoms/events.  It is unknown if there were lab data/results available.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (illness).  At time of reporting, the outcome was Unknown for the event illness.
On 5/23 two days after vaccine  he was irritable, tired, fatigued, not sleeping well. He could not complete his track meet . He had abdominal pain, felt bloated, and he felt this nausea & discomfort. He thought he might be constipated, so he took MiraLAX and then he had diarrhea all day yesterday. on 5/26   he had a temperature of 99.2, he had acute chest pain retrosternal and feeling of compression on the chest, head fullness as if he is going to explode. He had nausea, insomnia. Ibuprofen was given to him by his mother and this helped a lot But  he woke up on  morning of 5/27 , but the chest pain returned with increased pressure, very nauseous, agitated, unable to be comfortable. No fever,,  the pain was a sharp pressure. He had no syncope or chest shortness of breath He was seen at Hospital ER where a chest x-ray was normal. Echocardiogram was done, ,noted to  have EKG changes. Troponin was elevated. He had a cardiac catheterization done emergently at hospital through the right radial artery and was noted to have normal coronaries.  He also had a chest x-ray done which was negative for pulmonary lesions, and his abdominal pain he says was relieved after the MiraLAX and the diarrhea. His  twin sister who received the vaccine 15 minutes after him is completely asymptomatic.
Eye swelling; This non-serious case was reported by a pharmacist and described the occurrence of eye swelling in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12-JAN-2023, the patient received the 1st dose of Shingrix. On 12-JAN-2023, less than a day after receiving Shingrix, the patient experienced eye swelling (Verbatim: Eye swelling). On 15-JAN-2023, the outcome of the eye swelling was resolved (duration 3 days).   It was unknown if the reporter considered the eye swelling to be related to Shingrix.     It was unknown if the company considered the eye swelling to be related to Shingrix.   Additional Information: GSK receipt date: 01-MAY-2023 This report was submitted via the online direct entry reporting system.  The reporter reported that the patient received first dose of Shingrix and eye swelled up for 2-3 days after.  The pharmacist wanted to see if that was a side effect of vaccine.  The patient was not on GSK program. The reporter did not consent to follow up.
Pt developed swelling with a hard knot at injection site along with redness and fever at injection site.
I started feeling weird a little dizzy, chest pain, seen by paramedics on site. Blood Pressure slightly elevated lasted about 30 minutes. Fever, chills for about 3 days.
On April 7 (six days after the vaccine) my mother experience a sharp pain on her left arm, radiating to her neck, back and finally chest. We went to emergency department, and she had EKG, CT Scan, X-Rays, MRI and blood work and could not find anything. She was discharge but the pain didnt go away. She is still in pain but less than before.
Patient seen in the emergency department on 5/28 for testicular pain and was admitted for scrotal cellulitis. During admission, also endorsed sore throat and cough, ultimately tested positive for Covid-19 via PCR on 5/29. Was placed on 4-5L supplemental O2 and eventually weaned to room air on 6/2, diagnosed with pneumonia due to Covid-19. Discharged on 6/3. This meets criteria for vaccine breakthrough case review.
Information has been received from a nurse concerning an 18 year old female with a history of a panic attack not related to GARDASIL who on 11-FEB-2008 was vaccinated intramuscularly with her first dose of GARDASIL (lot # not reported). On 07-MAY-2008 the patient was vaccinated intramuscularly with her second dose of GARDASIL (lot# reported as 657706/1439U). Following the vaccination on 07-MAY-2008, the patient experienced a panic attack, tingling in fingers, dizziness, felt faint and clammy. The patient's blood pressure prior to injection was 100/80 and her temperature was 98.8F. The patient was assisted to supine position and rested in office. The patient felt better after resting and was instructed to see her primary care physician. On 08-MAY-2008 the patient recovered from the panic attack, tingling in fingers, dizziness, feeling faint and clammy. Additional information has been requested.  07/08/2008 This is in follow-up to report(s) previously submitted on 6/13/2008. Initial information and follow up has been received from a nurse concerning an 18 year old female with an allergy to picolamine salicylate and omeprazole and a history of panic attacks not related to GARDASIL who on 11-FEB-2008 was vaccinated intramuscularly with her second dose of GARDASIL (lot# "reported as 657706/1493U"). On 30-APR-2008 the patient was vaccinated intramuscularly with her second dose of GARDASIL (lot# not reported). Following the vaccination on 30-APR-2008, the patient experienced a panic attack, tingling in fingers, dizziness, felt faint and clammy. The patient's blood pressure prior to injection was 100/80 and her temperature was 98.8F. The patient was assisted to supine position and rested in office. The patient felt better after resting and was instructed to see her primary care physician. On an unspecified date the patient recovered from the panic attack, tingling in fingers, dizziness, feeling faint and clammy.
The night after being vaccinated patient reports the injection site became red, swollen, and sore.  She took Tylenol for the pain with marginal benefit.  Patient reported to pharmacy the afternoon of 11/11 saying it seems to have been slowly improving, but the area was still slightly raised and about the diameter of a golf ball.  counseled patient to continue to monitor for improvement and consider using an ice pack on the site.
Headache, Myalgia, CoughWheeze, Diarrhea, NauseaVomiting, Tachycardia,   injection site pain, chills, insomnia, sneezing, rhinorrhea   Narrative: mild soreness at the injection site x2 days severe migraine x3 days;  other headache x6 days chills x3 days insomnia and disrupted sleep x2 days  tachycardia (HR 116-120bpm) x2 days body ache x5 days nausea and diarrhea  started 3 days after vaccine, resolved within 2 days sneezing, runny nose, cough x2  days
Tiredness; Mild headache; Chills; Achiness; receiving bivalent booster (5th dose); receiving bivalent booster (5th dose); This is a spontaneous report received from non-contactable reporter (Consumer or other non HCP) from a sales representative. The reporter is the patient.  An 80-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 4, SINGLE, UNKNOWN MANUFACTURE), for COVID-19 Immunization; Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 3, MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Tiredness"; HEADACHE (non-serious), outcome "unknown", described as "Mild headache"; CHILLS (non-serious), outcome "unknown"; PAIN (non-serious), outcome "unknown", described as "Achiness"; OFF LABEL USE (non-serious), IMMUNISATION (non-serious), outcome "unknown" and all described as "receiving bivalent booster (5th dose)". The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Approx 10 minutes after injection - pt developed red blotchy areas on neck and arms No itching No SOB. Benadryl 25 mg po provided. Back to surgery where she works.
On evening of 4th day after injection, my arm around the injection site became red and itchy.  It has continued into the 5th day.
Mild sore arm at injection site few hours after vaccine. Currently pregnant at 37 weeks, 6 days. Estimated delivery date is 3/28/2021.
I administered Vaxelis and PCV13 to catch up patient with immunizations, but it was too early and did not realize until the end of the visit.  Explained to mom what happened. Mother of patient did not return to clinic with any questions, concerns, or complaints of child feeling or having any reaction.
Pain at site radiating down arm cannot lift arm w/o sharp pain malaise, fatigue, brain fog.
2x2 inch circular red, warm to touch on right upper thigh. Tx: Benadryl, cold compress
Brainstem stroke occurred on 5/13/17. Was recovering well from stroke. Flu shot received on 11/1/2017. On 11/19/17 I took a motorcycle ride. It was cold and I was using heated gloves while on the bike. At the end of the ride, I removed my gloves and noticed that I had a second degree burn on my right hand and my left foot was blue. I had no sense of feeling in either my right hand or left foot.  Since that time, the lack of feeling has spread up to my right shoulder, left elbow, left knee and up to the right hip. I have become increasingly fatigued, and was prior to the flu shot, able to walk 3-4 miles/day, and now am able to only walk 1-2 miles before I become totally exhausted. I have had to stop my physical therapy, since I am so fatigued as well. As a result of my worsening condition, I sought medical advice at Clinic.
Body aches, fever of 100.3 degrees Fahrenheit, chills Treatment: Tylenol and rest Outcome: resolved after 24 hours
invalid dosing interval day 43; Vaccination Site Pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination Site Pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (invalid dosing interval day 43) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included Le Fort osteotomy (Underwent Maxilla Lefort surgery from tripping over dog at her house.) on 30-Mar-2021.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PAIN (Vaccination Site Pain). On 15-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (invalid dosing interval day 43). At the time of the report, VACCINATION SITE PAIN (Vaccination Site Pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (invalid dosing interval day 43) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.
Fever up to 104 then on 3/30 became more lethargic with altered mental status, severe acidosis, poor po intake. This required intubation for airway protection and IV fluid hydration.
No adverse effects; vaccinated with one dose of improperly stored PROQUAD; This spontaneous report as received from a registered nurse refers to a 10-year-old patient of unknown gender. The patient's pertinent medical history, concomitant medications, drug reactions and allergies were not reported.  On 30-JUL-2019, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) one dose (lot # R030803, expiration date: 22-APR-2020, exact dose and route of administration were not reported) that was reconstituted with properly stored sterile diluent (lot number and expiration date not reported) for prophylaxis. From an unspecified date, measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was stored in temperature range of 6 Fahrenheit degrees to 14 Fahrenheit degrees for 24 hours. There was no previous temperature excursion. No adverse effects were reported. Call was because of digital data logger.
flu symptoms; felt pretty miserable/ miserable all day; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu symptoms), FEELING ABNORMAL (felt pretty miserable/ miserable all day) and PYREXIA (low grade fever) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 01SM20) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu symptoms), FEELING ABNORMAL (felt pretty miserable/ miserable all day) and PYREXIA (low grade fever). On 10-Mar-2021, INFLUENZA LIKE ILLNESS (flu symptoms), FEELING ABNORMAL (felt pretty miserable/ miserable all day) and PYREXIA (low grade fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 100 (High) 100 degrees Fahrenheit.         No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-033598 (Patient Link).
This is an instance of breakthrough COVID-19 disease after which death occurred.   The individual was vaccinated with the Moderna product on 01/18/2021 and 02/15/2021. The specific symptom onset date is not known, but the individual reported being ill "for several days" when they presented for COVID-19 testing on 08/26/2021 and were found to be positive for COVID-19 via PCR test. They presented to emergency department on 08/27/2021 with primary complaints of weakness, hypoxia, and altered mental status. The individual was not oriented to time or place upon presentation to emergency department. The individual had an ongoing urinary tract infection during this time as well. The individual was admitted to hospital on 08/27/2021. They remained hospitalized until their death on 09/03/2021.
Left arm rash redness at site developed on the eighth day  4 inch x 4 inch,  increased back pain with Lt leg sciatica unknown if related
Flu symptoms; Chills; Fever; Aches; Fatigue; This case was reported by a physician via call center representative and described the occurrence of flu symptoms in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th January 2020, the patient received Shingrix. On an unknown date, less than 3 weeks after receiving Shingrix, the patient experienced flu symptoms, chills, fever, pain and fatigue. On an unknown date, the outcome of the flu symptoms, chills, fever, pain and fatigue were recovered/resolved.   It was unknown if the reporter considered the flu symptoms, chills, fever, pain and fatigue to be related to Shingrix.  Additional information was provided as follows: The patient experienced flu symptoms, chills, fever, aches and fatigue. The adverse events lasted for 2 days. The reporter consented to follow up. The batch number and expiration date was not provided as the reporter mentioned that the information was at the facility and did not have the details at the moment.
This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (inflammation down her armpit) and PYREXIA (fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 059h21a and 003b21a) for COVID-19 vaccination. Concurrent medical conditions included Hemorrhoids. Concomitant products included DIOSMIN (DAFLON [DIOSMIN]) for Hemorrhoids.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Dec-2021, the patient experienced INFLAMMATION (inflammation down her armpit) and PYREXIA (fever). The patient was treated with ACETAMINOPHEN for Adverse event, at a dose of 1000 mg. At the time of the report, INFLAMMATION (inflammation down her armpit) and PYREXIA (fever) outcome was unknown.
Sore throat (external), swelling to the right side of the throat. Healthcare professional ruled out Covid, strep throat, and flu.
flu like symptoms; This is a spontaneous report from a contactable physician (patient). An unknown age and gender patient received 1st and 2nd dose of BNT162B2 (COVID 19 vaccine) at single dose for covid-19 immunization. Medical history and concomitant drug were not reported. Patient experienced flu like symptoms after 2nd dose of the Covid 19 vaccine. Subsided the following day. Was able to go for a run. Symptoms were more severe after 2nd dose than first. Event took place after use of product. Outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
I became ill the day after the shot. The following day I had absolutely no voice. I?ve never lost my voice in my life.  5 days after my second dose I began having chest pains. I've never experienced chest pains. These have been occurring now daily at rest and I started having SOB. I had an ekg done and it came back abnormal. I?ve never had an abnormal ekg. I am waiting the results of a stress test/echo. I was placed on an inhaler and they want me to see a pulmonologist now. Thinking maybe seasonal asthma. This all started after my vaccine. I?m 40 years old. I?ve never had seasonal asthma or asthma of any kind now I choke every morning.  My chest hurts and just doesn't feel right. Could it all be coincidence- maybe but it just isn't sitting well with me the timing of the symptoms and the vaccine.
24 hrs after immunization, had rotator cuff type pain, especially when reaching. Arm goes limp and painful upon most but not all movements. Debilitating. Struggling to changes clothes by onseself. Pain/unable to reach to wash hands without good arm assisting. Seems like SIRVA possibly due to bad injection location. Headed to urgent care today. Problem is with medical service injecting too high on the arm (1-2 fingers width down instead of 3 fingers width down). Also provider stood while patient sal.
Pt is here with right arm swelling redness and pain. Swelling & redness started in upper arm but is now around the forearm and elbow. morphine 4mg IV, clindamycin 900mg IV SOLU-MEDEROL 125mg IV.
EXPIRED VACCINE USED; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 06-AUG-2021, the patient experienced expired vaccine used. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine used was not reported. This report was non-serious. This case, from the same reporter is linked to 20210815116.
This is a 74y.o. male admitted from home after he had a syncopal episode after going to the bathroom patient is somewhat confused is not sure if he had a bowel movement forehead P he states as he was leaving the bathroom and collapsed on the floor patient does remember that otherwise he has amnesia the exact event previous history of CVA and hypertension family history of diabetes patient is married he does not drink he may smoke patient is unsure of his history he apparently was positive for Covid but was not aware of being exposed to anybody nor having any specific Covid symptoms. Patient has no known allergies. He takes medication for his blood pressure.
Phone call from client, states she has a red, raised rash at the site of a Japanese Encephalitis injection received on 06/20/05.  Stated started as red,raised area then developed a rash on her arm.  Denied head aches, fever, systemic rash or resp difficulty.  Declined to come to clinic for check.  Encouraged to try otc Benadryl for relief of symptoms.  Seek care if s/s worsen.